"Endospan hits enrolment milestone in aortic arch stent trial " was originally created and published by Medical Device ...

Endospan announced today that it completed enrollment for the primary arm of its TRIOMPHE FDA investigational device ...

Endospan, a pioneer in endovascular solutions for the Aortic Arch, today announced the completion of enrollment for the ...

Endospan announced the completion of enrollment for the primary arm of its TRIOMPHE investigational device exemption (IDE) ...

A noteworthy case study. What can be done for a 16-year-old girl with chest pain and worsening dyspnea? That's what ...

Zymeworks has dosed the first subject in a Phase I trial of ZW171 to treat ovarian cancer, non-small cell lung cancer and ...